Spyglass Capital Management LLC Dexcom Inc Transaction History

Spyglass Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$78.0 - $104.5 $40,092 - $53,713	-514 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$62.68 - $105.34 $4.26 Million - $7.16 Million	-67,971 Reduced 99.25%	514 $208,000
Q1 2020 May 15, 2020	SELL	$47.79 - $75.63 $1.99 Million - $3.15 Million	-41,624 Reduced 37.8%	68,485 $18.4 Million
Q4 2019 Feb 14, 2020	BUY	$36.62 - $57.29 $511,141 - $799,653	13,958 Added 14.52%	110,109 $24.1 Million
Q3 2019 Nov 14, 2019	SELL	$35.53 - $43.8 $569,688 - $702,289	-16,034 Reduced 14.29%	96,151 $14.4 Million
Q2 2019 Aug 14, 2019	BUY	$27.84 - $38.92 $575,090 - $803,970	20,657 Added 22.57%	112,185 $16.8 Million
Q1 2019 May 15, 2019	BUY	$28.07 - $38.18 $1.12 Million - $1.52 Million	39,834 Added 77.06%	91,528 $10.9 Million
Q4 2018 Feb 14, 2019	BUY	$26.99 - $37.37 $1.4 Million - $1.93 Million	51,694 New	51,694 $6.19 Million

1,023

353M

5.51M

5.61M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $33.5B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Spyglass Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Spyglass Capital Management LLC with notifications on news.